HOXA10 expression is decreased in endometrium of women with adenomyosis
Other
OA: closed
CC0
⤵ 74 in-corpus citations
AI-generated summary
This study investigated HOXA10 expression in the endometrium of women with adenomyosis, finding a decrease in its levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
HOXA10 gene expression is decreased in the secretory phase endometrium of women with adenomyosis. Diminished expression of HOXA10 is a potential mechanism explaining decreased implantation observed in women with adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (56)
- Aberrant integrin expression in the endometrium of women with endometriosis via openalex
- Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis via openalex
- Adenomyosis--a result of disordered stromal differentiation via openalex
- Adenomyosis at hysterectomy: prevalence and relationship to operative findings and reproductive and menstrual factors via openalex
- Differential expression and localization of de-novo synthesized endometriotic haptoglobin in endometrium and endometriotic lesions via openalex
- Effect of endometriosis on in vitro fertilization via openalex
- Endometrial HOXA10 expression after controlled ovarian hyperstimulation with recombinant follicle-stimulating hormone via openalex
- Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium via openalex
- HOX gene expression is altered in the endometrium of women with endometriosis via openalex
- Leukemia inhibitory factor is dysregulated in the endometrium and uterine flushing fluid of patients with adenomyosis during implantation window via openalex
- Prevalence and risk factors of adenomyosis at hysterectomy via openalex
- Regulation of HOXA-10 and its expression in normal and abnormal endometrium via openalex
- Salpingectomy increases peri-implantation endometrial HOXA10 expression in women with hydrosalpinx via openalex
- The elusive adenomyosis of the uterus--revisited via openalex
- Uterine adenomyosis in the infertility clinic via openalex
- W2072840911 via openalex
- W2073456100 via openalex
- W2078214818 via openalex
- W2083467689 via openalex
- W2093826944 via openalex
- W2105821207 via openalex
- W2107490653 via openalex
- W2111107089 via openalex
- W2112908989 via openalex
- W2121605257 via openalex
- W2127396401 via openalex
- W2135280659 via openalex
- W2137050072 via openalex
- W2137460866 via openalex
- W2137799669 via openalex
- W2165037167 via openalex
- W2166826551 via openalex
- W2167483148 via openalex
- W2276863329 via openalex
- W2319224462 via openalex
- W4243015558 via openalex
- W4295689030 via openalex
- W6641528351 via openalex
- W6645299560 via openalex
- W6681467470 via openalex
- W1561363733 via openalex
- W6712010351 via openalex
- W1756010385 via openalex
- W1962519237 via openalex
- W1965039757 via openalex
- W1968145124 via openalex
- W1980179310 via openalex
- W1997750775 via openalex
- W1999435017 via openalex
- W2003738260 via openalex
- W2016502542 via openalex
- W2040981815 via openalex
- W2047238631 via openalex
- W2049175197 via openalex
- W2051150230 via openalex
- W2054569293 via openalex
Cited by (50)
- Gonadotropin-releasing hormone agonist (GnRH-a) pretreatment duration and letrozole supplementation for optimizing live birth rates in women with adenomyosis undergoing frozen-thawed embryo transfer (GOLD-FET): study protocol for a multicenter, 2 × 2 factorial randomized controlled trial in China 2026
- Changing the paradigm of endometriosis - from diagnosis to integrated long-term management: a joint society opinion paper 2026
- The downregulation of FKBP5 contributes to the pathogenesis of adenomyosis and is associated with impaired endometrial receptivity† 2025
- The Impact of Uterine Disorders on Embryo Implantation and Early Survival: From Molecular Insights to Clinical Evidence 2025
- The Impact of Uterine Disorders on Embryo Implantation and Early Survival: From Molecular Insights to Clinical Evidence 2025
- Fertility outcome following ovarian stimulation in infertile women having pretreatment with levonorgestrel releasing intrauterine system versus dienogest for symptomatic adenomyosis 2025
- Transcriptome analysis of adenomyosis eutopic endometrium reveals molecular mechanisms involved in adenomyosis-related implantation failure and pregnancy disorders 2024
- The Art of Managing Infertile Patients with Adenomyosis 2024
- Adenomyosis, especially in its focal nature, hampers implantation and live birth rate after single euploid embryo transfer 2024
- Association between Uterine Adenomyosis and Infertility: Role of Axonemal Alteration in Apical Endometria 2024
- The administration of long in-vitro fertilization protocol in adenomyosis: case series 2024
- Role of HOXA10 in pathologies of the endometrium 2024
- Adenomiosis: diagnóstico 2023
- Adenomyosis: In-Vitro Fertilization Does Not Improve Pregnancy Outcome as Compared to Conventional Infertility Treatment 2023
- Expression of HOXA10 Gene in Women with Endometriosis: A Systematic Review 2023
- The role of <i>WNT</i> and <i>HOXA</i> signaling cascades in the pathogenesis of adenomyosis 2023
- Pathogenesis of Human Adenomyosis: Current Understanding and Its Association with Infertility 2022
- Decreased intracellular IL-33 impairs endometrial receptivity in women with adenomyosis 2022
- Adjustment of progesterone administration after endometrial transcriptomic analysis does not improve reproductive outcomes in women with adenomyosis 2022
- Endometriosis-associated infertility: From pathophysiology to tailored treatment 2022
- Adenomyosis decreases the live birth rate but may not affect perinatal outcomes in assisted reproductive cycles 2022
- How does adenomyosis impact endometrial receptivity? An updated systematic review of clinical and molecular insights 2022
- Melatonin improves pregnancy outcomes in adenomyosis mice by restoring endometrial receptivity via NF-κB/apoptosis signaling 2022
- Extracellular vesicles secreted by adenomyosis endometrial organoids contain miRNAs involved in embryo implantation and pregnancy 2022
- Comparison of oocyte count, fertilization, and pregnancy rates in adenomyosis patients undergoing In Vitro Fertilization with short and long protocol controlled ovarian stimulation - Restospective study 2022
- Establishment of Adenomyosis Organoids as a Preclinical Model to Study Infertility 2022
- Infectious and noninfectious endometritis and recurrent pregnancy loss 2022
- Biomechanical Forces Determine Fibroid Stem Cell Transformation and the Receptivity Status of the Endometrium: A Critical Appraisal 2022
- Epigenomic Analysis Reveals the KCNK9 Potassium Channel as a Potential Therapeutic Target for Adenomyosis 2022
- Recent Advances and Current Perspectives on Endometrial Receptivity 2021
- Insights Gained from Genomic Studies on the Role of Sex Steroids in the Aetiology of Endometriosis 2021
- Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis 2021
- Recent Advances and Current Perspectives on Endometrial Receptivity 2021
- Adenomyosis and Infertility-Review of Medical and Surgical Approaches 2021
- Impaired decidualization of human endometrial stromal cells from women with adenomyosis† 2021
- Scribble downregulation in adenomyosis compromises endometrial stromal decidualization by decreasing FOXO1 expression 2021
- FACTORS OF ENDOMETRIAL RECEPTIVITY DOWN-REGULATION IN GENITAL ENDOMETRIOSIS 2020
- Determining the Molecular Background of Endometrial Receptivity in Adenomyosis 2020
- Large, Non-Cavity Distorting Intramural Leiomyomas Decrease Leukemia Inhibitory Factor in the Secretory Phase Endometrium 2020
- Adenomyosis: Mechanisms and Pathogenesis 2020
- TGF-β1 Neutralization Improves Pregnancy Outcomes by Restoring Endometrial Receptivity in Mice with Adenomyosis 2020
- Faculty Opinions recommendation of Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment. 2019
- Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity 2019
- THE ROLE OF MORPHOFUNCTIONAL CHANGES OF THE UTERUS IN THE DEVELOPMENT OF REPRODUCTIVE DISORDERS IN WOMEN WITH ADENOMYOSIS 2019
- Preliminary functional inquiry of lncRNA ENST00000433673 in embryo implantation using bioinformatics analysis 2019
- Adenomyosis and Infertility 2019
- Classification and Reporting Systems for Adenomyosis 2019
- Decreased Endometrial IL-10 Impairs Endometrial Receptivity by Downregulating HOXA10 Expression in Women with Adenomyosis 2018
- Adenomyosis and Subfertility 2018
- Endometrial L-selectin ligand is downregulated in the mid-secretory phase during the menstrual cycle in women with adenomyosis 2018
Source provenance
- europepmc
- last seen: 2026-10-12T06:17:10.165071+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:08:15.389298+00:00
License: CC0
· commercial use OK